Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes

Transplantation

Volumn 63, Issue 2, 1997, Pages 293-298

  Marks, William H ^a   Ma, Yan ^a   Yirdaw, Getachew ^a   Florence, Lisa ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; ASIALOOROSOMUCOID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; TRITIUM;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG UPTAKE; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CULTURE; LIVER TRANSPLANTATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0030933999     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00020     Document Type: Article

References (32)

1. Sandborn WJ, Lawson GM, Krom RAF, Wiesner RH. Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection. Hepatology 1992; 15: 1086.
2. Sandborn WJ, Lawson GM, Cody TJ, et al. Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue. Hepatology 1995; 21: 70.
3. Rice KG, Weisz OA, Barthel T, Lee RT, Lee YC. Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat hepatocytes. J Biol Chem 1990; 265: 18429.
4. Hu WL, Regoeczi E, Chindemi PA, Bolyos M. Lactoferrin interferes with uptake of iron from transferrin and asialotransferrin by the rat liver. Am J Physiol 1993; 264: G112.
5. Harada M, Sakisaka S, Yoshitake M, et al. Ultrastructure of intracellular membranous system and intracellular transport of asialoglycoproteins in rat hepatocytes. J Electron Microsc (Tokyo) 1992; 41: 458.
6. Treichel U, Schreiter T, Meyer zum Buschenfelde KH, Stockert RJ. High-yield purification and characterization of human asialoglycoprotein receptor. Protein Expr Purif 1995; 6: 251.
7. Ozaki K, Lee RT, Lee YC, Kawasaki T. The differences in structural specificity for recognition and binding between asialoglycoprotein receptors of liver and macrophages. Glycoconj J 1995
8. Weiss P, Ashwell G, Morell AG, Stockert RJ. Modulation of the asialoglycoprotein receptor in human hepatoma cells: effect of glucose. Hepatology 1994; 19: 432.
9. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29.
10. Johnstone A, Thorpe R. Immunochemistry in practice. 1987:266.
11. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2: 100.
12. Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in nagase rats. J Biol Chem 1991; 266: 14338.
13. Wu GY, Keegan-Rogers V, Franklin S, Midford S, Wu CH. Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro. J Biol Chem 1988; 263: 4719.
14. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system [erratum: J Biol Chem 1988; 263: 588]. J Biol Chem 1987; 262: 4429.
15. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263: 14621.
16. Wu GY, Wu CH. Delivery system for gene therapy. Biotherapy 1991; 3: 87.
17. Keegan-Rogers V, Wu GY. Targeted protection of hepatocytes from galactosamine toxicity in vivo. Cancer Chemother Pharmacol 1990; 26: 93.
18. van Dijk W, Havenaar EC, Brinkman-van der Linden EC. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Clycoconj J 1995; 12: 227.
19. Zeng FY, Weigel PH. Hydroxylamine treatment differentially inactivates purified rat hepatic asialoglycoprotein receptors and distinguishes two receptor populations. J Biol Chem 1995; 270: 21388.
20. Nakaya R, Kohgo Y, Mogi Y, Nakajima M, Kato J, Niitsu Y. Regulation of asialoglycoprotein receptor synthesis by inflammation-related cytokines in HepG2 cells. J Gastroenterol 1994; 29: 24.
21. Yago H, Kohgo Y, Kato J, Watanabe N, Sakamaki S, Nitsu Y. Detection and quantification of soluble asialoglycoprotein receptor in human serum. Hepatology 1995; 21: 383.
22. Schwartz AL. Trafficking of asialoglycoproteins and the asialoglycoprotein receptor. Targeted Diagn Ther 1991; 4: 3.
23. Fung J, Abu-Elmagd K, Jain A, et al. A randomized trial of primary liver transplantation under immunosuppression with FK506 vs cyclosporine. Transplant Proc 1991; 23: 2977.
24. Stepkowski S, Goto S, Reynolds K, Kahan BD. Induction of unresponsiveness after local low-dose cyclosporine administration. Transplant Proc 1989; 21: 1120
25. Dowling RD, Zenati M, Burkart GJ, et al. Aerosolized cyclosporine as single-agent immunotherapy in canine lung allografts. Surgery 1990; 21: 1120.
26. Keenan RJ, Duncan AJ, Yousem SA, et al. Improved immuno-suppression with aerosolized cyclosporine in experimental pulmonary transplantation. Transplantation 1992; 53: 20.
27. Wang X, Berrezniak R, Tafra L, Posselt A, Barker CF, Dafoe DC. Intraportal FK506 improves intrahepatic islet allograft survival. Transplant Proc 1991; 23: 3211.
28. Gruber SA, Hrushesky WJM, Cipolle RJ, et al. Local immuno-suppression with reduced systemic toxicity in a canine renal allograft model. Transplantation 1989; 48: 936.
29. Demetris AJ, Fung JJ, Todo S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy - a clinicopathologic study of 96 patients. Transplantation 1992; 53: 1056.
30. Gruber SA. Locoregional immunosuppression of organ transplants. Immunol Rev 1992; 129: 5.
31. Hess AD, Tutschka PJ, Santos GW. Effect of cyclosporine A on human lymphocyte response in vitro: III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol 1982; 128: 355.
32. Tocci MJ, Matkovich DA, Collier KA, et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718.29.